Metdose GP 2mg/500mg/15mg Tablet SR
Marketer
Medxone Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metdose GP 2mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication for managing blood glucose. This treatment, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Metdose GP tablets. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption as it may heighten the risk of certain side effects.
Primary Ingredients of Metdose GP 2mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Metdose GP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metdose GP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metdose GP 2mg/500mg/15mg Extended-Release Tablets with a meal.
Common Side effects of Metdose GP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metdose GP 2mg/500mg/15mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metdose GP 2mg/500mg/15mg Extended-Release tablets with food.
How Metdose GP 2mg/500mg/15mg Tablet SR works:
Metdose GP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy offers superior blood glucose management when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Metdose GP 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metdose GP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing this medication. Seek medical advice from your doctor.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet Metdose GP (2mg/500mg/15mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when prescribing Metdose GP 2mg/500mg/15mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before administering. This medication is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metdose GP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Metdose GP 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Metdose GP 2mg/500mg/15mg Tablet SR :
Should you forget to take your Metdose GP 2mg/500mg/15mg SR Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Metdose GP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Medication |
3,018 People bought this recently